A variant erythroferrone disrupts iron homeostasis in SF3B1 -mutated myelodysplastic syndrome

0 avis

A variant erythroferrone disrupts iron homeostasis in SF3B1 -mutated myelodysplastic syndrome

Archive ouverte

Edité par CCSD ; American Association for the Advancement of Science (AAAS) -

International audience. A variant erythroferrone contributes to hepcidin modulation and systemic iron accumulation in patients with SF3B1 -mutated myelodysplastic syndrome.

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome

Archive ouverte | Bondu, Sabrina | CCSD

International audience. Myelodysplastic syndromes (MDS) with ring sideroblasts are hematopoietic stem cell disorders with erythroid dysplasia and mutations in the SF3B1 splicing factor gene. Patients with MDS with S...

Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation

Archive ouverte | Rombaut, David | CCSD

International audience. Myelodysplastic syndromes (MDS) with mutated SF3B1 gene present features including a favourable outcome distinct from MDS with mutations in other splicing factor genes SRSF2 or U2AF1 . Molecu...

Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes

Archive ouverte | Park, Sophie | CCSD

International audience. Erythropoiesis-stimulating agents are generally the first line of treatment of anemia in patients with lower-risk myelodysplastic syndrome. We prospectively investigated the predictive value ...

Chargement des enrichissements...